Related Experiment Videos
[Pulmonary Langerhans'-cell histiocytosis]
A M García Bernárdez1, C C Alvarez Cuesta, M E Rivas Carmenado
1Servicio de Medicina Interna I, Hospital Universitario Central de Asturias, Oviedo, Asturias.
Anales De Medicina Interna (Madrid, Spain : 1984)
|March 29, 2006
Summary
Pulmonary Langerhans' cell histiocytosis (PLCH) is a rare lung disease primarily affecting smokers. Smoking cessation led to significant symptom improvement and radiographic healing in one patient with PLCH.
Area of Science:
- Pulmonology
- Oncology
- Cell Biology
Background:
- Pulmonary Langerhans' cell histiocytosis (PLCH) is a rare interstitial lung disease.
- It involves the monoclonal proliferation and organ infiltration by Langerhans' cells.
- PLCH predominantly affects cigarette smokers and has an unpredictable clinical course.
Observation:
- This report details a case of PLCH in an adult patient.
- The patient presented with symptoms and radiographic findings consistent with PLCH.
- The patient's smoking history was a significant factor.
Findings:
- The patient underwent smoking cessation.
- Following smoking cessation, objective radiographic improvement was observed.
- Complete disappearance of clinical symptoms was noted post-cessation.
Implications:
- Smoking cessation appears to be a critical therapeutic intervention for PLCH.
- This finding suggests a direct link between smoking and PLCH progression.
- Further research into the mechanisms of PLCH and smoking cessation benefits is warranted.